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Markers of Apoptosis: Methods for Elucidating
the Mechanism of Apoptotic Cell Death from the
Nervous System
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Dartmouth Medical School,
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ABSTRACT
Apoptosis is a highly conserved energyrequiring program for non-inflammatory
cell death that is important in both normal
physiology and disease. Numerous techniques have been used to study apoptosis. In
the nervous system, apoptosis is necessary
for normal development, but it also occurs
in many acute and chronic pathologic conditions. This review places commonly used
markers of apoptosis and their detection in
the context of what is now known about the
process of apoptosis. We review the potential
role of apoptosis in nervous system and neurodegenerative disorders (Alzheimer’s disease, Parkinson’s disease, and amyotrophic
lateral sclerosis). We then describe important morphological, immunocytochemical,
and molecular genetic markers for apoptosis, including proteases, signal transduction
molecules, and mitochondrial proteins. The
possibility of manipulating apoptosis therapeutically in conditions of too many or too
few cells is under active investigation.
648 BioTechniques

INTRODUCTION
Advances in genetics, molecular biology, and immunology have allowed
more detailed study of the cellular
mechanisms of apoptotic death, and
biochemical markers unique to apoptosis have been sought among the molecular changes that enact and accompany
it. This research has demonstrated intermediate states that show characteristics
of both apoptotic and non-apoptotic cell
death (25,49) and mediators common to
both apoptosis and necrosis (55). For
example, cells protected from glutamate-induced necrotic death by glutamate inhibitors may, under further
stress, die by apoptosis (49). Although
apoptosis is thought to occur by the activation of cysteine proteases that cleave
behind aspartate residues, called caspases, there is evidence for caspase-independent apoptosis in mouse embryogenesis (33). Finally, the presence of
caspases locally in dendrites and their
possible role in synaptic plasticity as
well as cell death (41) suggest more
complex roles for these proteases involving signal transduction. Thus, there
is a continuum of pathways to cell death
rather than an invariant “all or nothing”.
Considering the clinical relevance of
apoptosis, it is important to determine
whether it causes or occurs in response
to the disease in question. The advances
and refinement of techniques used to
detect apoptosis constitute important
milestones in the design of therapeu-

tics. It is thus important to ask whether
increasing or decreasing apoptosis
leads to demonstrable benefit. There is
some evidence that this may be so, at
least in Drosophila: ninaE-rh27 rhodopsin mutants expressing the antiapoptotic caspase-inhibiting baculovirus gene p35 retained significantly
better visual function as measured by a
behavioral assay of oculomotor walking response than their light-reared ninaE-rh27 counterparts without the
apoptosis-inhibiting gene (13). Yet, inhibiting apoptosis may simply cause a
cell to die by necrosis (28), since inflammation results. Another potentially
important limitation on manipulating
apoptosis is that exceeding the capacity
of clearance mechanisms to remove
apoptotic bodies may induce necrosis
(26). After briefly describing apoptosis
in the nervous system, we will review
morphological, immunochemical, and
genetic markers for detecting apoptosis.
INDUCERS OF APOPTOSIS
Programmed cell death is induced
by many stimuli, including stress, hypoxia, radiation, trauma, and glutamate
excitotoxicity. Apoptosis occurs as part
of normal development and homeostasis but has also been demonstrated in
pathologic conditions of the nervous
system such as Alzheimer’s disease,
Parkinson’s disease, stroke, brain trauma, and amyotrophic lateral sclerosis
Vol. 32, No. 3 (2002)

(ALS). Apoptosis has been demonstrated in many organ systems, but there are
significant differences in the kinds of
signals that result in programmed cell
death from tissue to tissue. In the developing and mature nervous system, the
absence of a signal often initiates the
apoptotic death cascade. Developing
neurons in particular are poised to destroy themselves; the absence of
growth factors at a tyrosine kinase receptor of the plasma membrane enables
the dephosphorylated pro-apoptotic
BAD protein to bind to Bcl-2, permitting the release of cytochrome c from
mitochondria and the activation of caspase 3, a member of the family of cysteine proteases that affect the death program (16). In contrast, cells of the
immune system also employ a ligandmediated signaling system involving
the Fas death receptor (also known as
CD95 and a member of the tumor
necrosis factor receptor family) to activate caspases to the same self-destructive end. Numerous inducers of apoptosis in the central nervous system (CNS)
have been identified. The following
methods for inducing apoptosis have
potential therapeutic relevance.
Stress may take the form of changing extracellular ion concentrations and
the absence of a normal extracellular
serum milieu, with resultant production
of reactive oxygen species. In such circumstances, cerebellar granule neurons
undergo apoptotic death and may be
rescued by brain-derived neurotrophic
factor and other trophic factors (53). In
cultured cortical neurons, hydroxyl radicals generate internucleosomal cleavage of DNA, but not other apoptotic
morphologic features (31). Cyanide-induced hypoxia can cause apoptosis in
differentiated PC12 cell cultures, as
shown by oligonucelosomal fragmentation of DNA and electron microscopy;
cell death was partially blocked by antioxidants ascorbate and catalase (43).
Chronic oxidative stress also increases
susceptibility to apoptotic cell death (3;
see below on Cu/Zn superoxide dismutase). Heat (22) and pressure (1) have
also been associated with apoptosis.
Hypoxia may be transient or prolonged, global or focal, and affects
apoptotic cell death in both embryonic
and mature neurons. It is also important in tumor surveillance. In the emVol. 32, No. 3 (2002)

bryo, relative hypoxia is required for
both apoptosis and normal morphology
(10). The newborn piglet brain shows
interesting regional differences during
transient global ischemia: cerebellar
Purkinje cells do not die by apoptosis,
while cerebellar granule cells often do.
Less mature inner neurons of the hippocampal dentate region died by apoptosis, while more mature adjacent cells
died by necrosis (71). In many tumors,
regional hypoxia upregulates p53,
which promotes apoptotic tumor cell
death. In hepatocytes, hypoxia leads to
apoptosis via the inhibition of gluconeogenesis. In stroke, both oxygen and
glucose are decreased.
Glutamate excitotoxicity and excess
calcium entry are important in necrotic
cell death following ischemic cell injury
(52). Ischemic models in mice with
transient glucose and oxygen deprivation produce necrosis that can be
partially prevented by glutamate antagonists. If this protective effect is overwhelmed by prolonged insult, cell death
characteristic of apoptosis results and
can be inhibited by the protein synthesis
inhibitor cyclohexamide. There is evidence for apoptotic cell death in cells of
the hippocampus following global ischemia and in the penumbra surrounding necrotic regions of focal ischemic
injury (37). There is also evidence that
inhibiting apoptosis in stroke can reduce infarct volume (21). For a review
of apoptosis in stroke, see Reference 55.
Glutamate excitotoxicity is particularly relevant in the nervous system
since many neurons express both
NMDA and AMPA glutamate receptors, and their interplay may modulate
apoptotic signals and cell death pathway decisions. Glutamate stimulation
at these receptors leads to depolarization and the influx of calcium. Low levels of glutamate depolarization actually
protect cultured cerebellar granule cells
from apoptotic death through non-depolarizing stimuli (69), yet over-stimulation can result in both apoptotic and
necrotic death. Glutamate concentrations change both acutely, as in stroke,
and chronically, which may play a role
in neurodegenerative disorders.
Experimentally altering extracellular
and synaptic glutamate concentration
induces DNA changes in vitro, and
chronic change in cerebellar cell cul-

tures induces reversible DNA nicking
and ultimately apoptosis (19). Though
much evidence points toward apoptotic
death following glutamate stimulation,
there is some evidence that glutamate
may cause toxic death by a non-apoptotic mechanism. In one report (38), the
alkaloid protein kinase inhibitor staurosporine and glutamate toxicity patterns were compared. Apoptotic nuclear
morphology and DNA fragmentation
was seen with the staurosporine but not
glutamate in cortical neuron cultures.
A recent report (27) in cortical and
hippocampal cultures indicates that
caspase-dependent degradation of the
AMPA subtype of glutamate receptors
occurs early during cell stress and may
favor apoptotic rather than necrotic cell
death. Combined with evidence in the
adult rat striatum of combined necrotic
morphology with the DNA-laddering
characteristic of apoptosis (49), this
further supports the notion of a continuum of cell death modes. Significantly,
merely activating caspases through an
excitotoxic stimulus does not necessarily commit neurons to apoptosis. There
appears to be a time window in which
the program may be reversed (18).
Radiation also induces apoptotic
cell death in neurons. In cultured
mouse hippocampal cells, ionizing radiation increased levels of tumor-suppressor and pro-apoptotic gene p53
product levels, which apparently triggered apoptosis. Caspase activity increased as well, but caspase inhibition
did not prevent apoptotic cell death
(34). Immature neurons are more likely
to undergo radiation-induced apoptosis
than mature neurons, but when treated
with high extracellular potassium to induce depolarization, these immature
neurons were resistant to ionizing radiation-induced apoptosis (61).
In cases of head trauma, increased
levels of bax and, in 30% of cases, p53
were found in tissue samples, while
bcl2 was not expressed (46). Cerebrospinal fluid (CSF) from severe head
trauma patients was found to inhibit
neutrophil apoptosis in cells collected
from healthy patients undergoing orthopedic surgery. Antibody-mediated
neutralization of the increased levels of
granulocyte-colony-stimulating factor
found in trauma patients reduced the
anti-apoptotic effect. (23).
BioTechniques 649
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Neurodegenerative Diseases and
Apoptosis

Table 1. Nuclear, Cytoplasmic and Membrane Changes After Exposure to Apoptosis-Inducing
Agents

Alteration in Apoptotic Parameters

In neurodegenerative disease such as
Alzheimer’s, genetic predisposition may
favor apoptosis. Familial early-onset
Alzheimer’s disease is associated with
alterations in the protein presenilin,
which interacts with and may affect the
processing of regulatory apoptotic proteins including Bcl-XL (68). P53 and
C95 proteins are also elevated in
Alzheimer’s disease (15). To what degree these relationships, and apoptosis
itself, is fundamental in Alzheimer’s or
other neurodegenerative diseases is unclear, since a more fundamental pathologic process may cause cell injury that
leads to apoptosis. One possibility is that
the DNA fragmentation seen in
Alzheimer’s disease results from prolonged metabolic disturbance and that
the predominant mode of cell death in
this disease is necrotic (58). Our recent
results using a number of sensitive
methods for detection of apoptosis show
that cortical cells overexpressing amyloid precursor protein (APP) undergo
apoptosis (6). In another familial neurodegenerative disease, ALS, mutations
in the Cu/Zn superoxide dismutase are
associated with increased apoptotic cell
death. Cultured mouse neurons overexpressing transgenic Cu/Zn SOD showed
increased susceptibility to kainic acid
mediated excitotoxic apoptosis that may
be due to chronic oxidative stress (3).
Apoptosis in Parkinson’s disease has
also been described (59), but its role and
extent have been questioned (5).
Dopamine and other catecholamines
may contribute to programmed cell
death directly and through a N-methyl
D aspartate (NMDA) receptor-mediated
mechanism (72). The latter mechanism
may play a role in other neurodegenerative diseases as well (66). Methods used
to detect apoptosis in Parkinson’s disease brains after autopsy showed apoptotic DNA fragmentation and caspase 3
activity only in microglia (32), perhaps
reflecting a slow rate of cell death with
subsequent ingestion of apoptotic bodies. Alternatively, apoptosis may not
play a prominent role in this disorder.
Moreover, in a mouse model of Parkinson’s disease, the use of caspase inhibitors caused a transition from apoptotic to necrotic death (30).
650 BioTechniques

Time After Treatment

Increase in caspase 3 activity

30 min

PARP Cleavage

1h

Chromatin Condensation

3–5 h

DNA Fragmentation

5h

Decrease in Cellular Metabolism

8–12 h

Membrane Permeability Compromised

8–12 h

Lamin β Cleavage

8–12 h

A summary time course of DNA damage and apoptosis after exposure to
staurosporine (0.1 µM) or etoposide (10 µM).

MARKERS OF APOPTOSIS
Recent advances in the development
of methods for the detection of apoptosis
have facilitated our understanding of the
signaling pathways involved in this
process. These markers include an increase in caspase 3 activity, poly(ADPribose) polymerase (PARP) cleavage,
chromatin condensation, DNA fragmentation, decreased cellular metabolism,
compromised membrane permeability,
and cleavage of nuclear envelope proteins (lamins). These are summarized
for cultured neuroblastoma cells in
Table 1 by time after exposure to the
apoptosis-inducing agents staurosporine
or etoposide (7). In addition, the release
of cytochrome c from mitochondria and
the change in mitochondrial membrane
potential are thought to occur relatively
early in apoptosis (see below). Morphological, immunochemical, and both proand anti-apoptotic genetic marker assays
are outlined below. It is generally accepted that both visualization of morphological changes and at least one other technique to detect DNA changes
should be used in combination when asserting the presence of apoptosis.
Morphological Markers of
Apoptosis
Cell and nuclear shrinkage with chromatin condensation and margination followed by karyorrhexis were visualized
in the early 1970s using electron microscopy (35). The cell then disintegrates into membrane-bound bodies ingested by nearby cells. These apoptotic

bodies contain nuclear fragments and intact organelles and may undergo secondary necrosis if not cleared promptly
(reviewed in Reference 26). An important membrane change in apoptosis involves the flipping of anionic phospholipids and phosphatidyl serine groups to
the outer surface of the membrane for
recognition by neighboring cells. In vitro detection of externalized phosphatidyl
serine can be achieved through interaction with the anticoagulant annexin V.
Annexin V conjugated to FITC binds to
the exposed phosphatidyl serine, thus allowing the detection of apoptosis by fluorescent microscopy or flow cytometry.
Chromatin condensation can be detected by dyes that bind to chromatin.
One method uses bisbenzamide, which
binds to normal and condensed chromatin; resulting patterns in the nuclei of
intact cells can be visualized by fluorescence microscopy. Cortical cultures
contain both neurons and glia. Neuronal nuclei can be readily visualized
by labeling neurofilaments with a neurofilament antibody and neuronal nuclear chromatin with bisbenzimine
(Figure 1A). Exposing cortical neurons
to glutamate results in chromatin condensation and shrunken nuclei (Figure
1B). The number of apoptotic nuclei after exposure to an apoptotic stimulus
can be quantified by counting total nuclei and expressing apoptotic nuclei as
a percent of total nuclei counted (6).
DNA Breaks
Single-stranded breaks can be detected by using the Klenow fragment of
Vol. 32, No. 3 (2002)
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endogenous DNA polymerase to catalyze the addition of biotin-labeled (and
unlabeled) deoxynucleotides to exposed
3OH ends of DNA fragments. Streptavidin-HRP conjugate is added and reacts with biotinylated nucleotides. The
product can be visualized in intact cells
under bright-field microscopy. The
technique also labels dsDNA breaks,
but under certain stimulus conditions,
single-stranded breaks may be seen
without double-stranded breaks in
apoptotic cells (19). Klenow fragmentation detection kits are available from
various companies including Oncogene
Research and Trevigen.
Double-stranded breaks are commonly visualized with terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-biotin nick end labeling

(TUNEL) techniques. Here, peroxidase
is used to detect digoxigenin-nucleotide
residues added to the 3OH ends of DNA
strand breaks by exogenous TdT. Reaction with diaminobenzadine (DAB)
generates a brown product that can be
visualized with light microscopy. Kits
are available for this technique as described above. TUNEL labels necrotic
and apoptotic DNA, and there is increasing caution in equating TUNELpositive nuclei with apoptosis (39). As
with chromatin labeling and Klenow
fragment techniques, TUNEL can give
quantitative measures of apoptosis
based on cell counting.
Figure 2 shows a comparison of
these three techniques. Cerebellar cultures were chronically exposed to L-αamino-adipate (LAA), an inhibitor of

the glutamate uptake transporter. No
changes in nuclear morphology were
seen when the cells were stained with
bisbenzamide (stains chromatin) or
Apoptag (a kit for TUNEL labeling that
labels mostly dsDNA breaks). Those
cells processed for in situ nick translation using the Klenow fragment of DNA
polymerase I (shows ssDNA breaks)
show changes as detected by the brown
reaction product (Figure 2) (19). Thus,
the Klenow fragment method is more
sensitive for detecting DNA breaks than
the other two methods in this system.
DNA Laddering
Detecting characteristic DNA fragmentation is a common method that
provides evidence for apoptosis. DNA
damage is not limited to apoptotic cells,
and an important function in healthy
cells is repairing damage that occurs
through a variety of processes. As related to apoptotic DNA damage per se, ssDNA breaks may precede doublestranded breaks. Ultimately the DNA is
cleaved between histones giving DNA
fragments of about 180 bp. DNA laddering, in which purified DNA extracts
are run electrophoretically on an
agarose gel, shows characteristic fragments generated by apoptotic-specific
endonuclease. Figure 3 shows a typical
DNA laddering on gel electrophoresis
(8). It is important to note that not all
cells that undergo apoptosis show DNA
fragmentation that can be visualized on
DNA laddering.
Common Immunochemical Markers
of Apoptosis

Figure 1. Cortical cells nuclei labeled with bisbenzimide. (A) Control cells were double-labeled with
an antibody to a neurofilament protein and with a secondary antibody conjugated to Texas Red® (red).
The nuclei of the same cells were stained with bisbenzimide (blue), and the cells were viewed under a
fluorescent microscope. By interchanging the fluorescent filters, the nuclei of neurons can be readily
identified. The normal nuclei are round and regular in shape. (B) Cortical cells treated with glutamate
(100 µM) for 12 h. Note the apoptotic nuclei (arrow) showing condensation of chromatin.
652 BioTechniques

ELISAs for histones can quantitatively detect DNA fragmentation in
ruptured cells. In this technique, an
anti-histone antibody labeled with biotin simultaneously binds to the histone
associated with cleaved DNA and to
streptavidin-coated plates. A second
antibody, anti-DNA peroxidase-conjugated-mouse-monoclonal antibody reacts with the DNA component of nucleosomes. Nucleosomes associated with
degraded DNA are then analyzed photometrically (Figure 4) (6–8).
PARP is an endogenous nuclear enzyme cleaved by caspases. It is activated
by binding to DNA nicks and breaks. It
Vol. 32, No. 3 (2002)

DRUG DISCOVERY

AND GENOMIC TECHNOLOGIES

functions in DNA repair and cell death
by catalyzing poly(ADP-ribosyl)ation
of nuclear proteins, including itself and
histone H1. The PARP inhibitor 3aminobenzamide prevents both this
function and internucleosomal DNA
cleavage in cells undergoing apoptosis
induced by DNA-damaging agents (70).
PARP cleavage by caspases in apoptosis
probably reflects a decoupling of DNA
damage from DNA repair. Whether this
happens before DNA nicks and breaks
in response to a feedforward signal or
after DNA damage as a direct response
to that damage is unknown.
In neuroblastoma apoptosis, PARP
cleavage and caspase 3 activity were
more sensitive for DNA damage and
may occur earlier than nick translation
(Table 1 and Figure 5A). PARP cleavage catalyzes ADP ribose polymer
linkage to PARP itself and possibly
other proteins. The process uses NAD+
as a substrate and releases nicotinamide, lowering NAD+ and ATP concentrations in the cell. PARP proteins
can be measured by protein isolation
followed by Western blotting and immunolabeling with PARP antibodies.
Antibodies that recognize the intact and
cleaved 85-kDa portion of PARP are
available commercially (e.g., BioMol,
Sigma Cell Biochem, and Santa Cruz
Chemicon). The role of PARP in apoptosis is reviewed in Reference 29.
Later in apoptosis, the lamin proteins surrounding the nuclear membrane are cleaved. Proteolytic breakdown may be dependent on the
apoptotic stimulus used, occurring relatively earlier in heat stress-induced
apoptosis versus radiation (22). Caspase 3 has been shown to cleave and activate protein kinase C in leukemia
cells, while caspase 6 cleaves lamin
(11). This protein and its cleavage
products can be analyzed with techniques analogous to those described for
PARP. Figure 5B illustrates increase in
a 43-kDa lamin cleavage product beginning about 8 h after apoptosis is induced in human neuroblastoma cells.

Other variables include the stimulus
used to induce apoptosis, whether the
experimental system is in vivo or in vitro, and what experimental organism is
used in transgenic studies. Despite multiple sources of complexity, the beginnings of an integrated description of
apoptosis exist. An enormous number of
experimental techniques have been applied to studying apoptotic cellular
processes; particularly important are
transgenic organisms that lack, overexpress, or have targeted mutations that

Genetic Markers of Apoptosis

Figure 2. Comparison of nuclear morphology changes using three different methods before and after exposure to apoptosis-inducing agents such as LAA glutamate or low K+ (5 mM) concentration. Cells stained with bisbenzamide were observed under the fluorescent microscope, and those
processed for ISNT or Apoptag were observed under a light microscope. Cells treated with LAA showed
no changes in nuclear morphology after staining with bisbenzimide or Apoptag. However, DNA damage
was observed in LAA-treated cells with the ISNT detection method. The results suggest that the ISNT
technique is more sensitive in detection of DNA damage than the other two methods.

The complete set of apoptosis effector and regulatory molecules and their
roles in different cell lines at different
developmental stages are unknown.
654 BioTechniques

impair protein product function. Caspase knockout mice are reviewed in Reference 42. Key components in emerging
apoptotic mechanisms include signaling, mitochondria, the bcl-2 protein family, effector proteases, and physiologic
control of apoptosis via tumor suppressor mechanisms. After a cell recognizes
a death signal, apoptosis proceeds
through the proteolytic activity of a family of cysteine proteases, the caspases,
that cleave after aspartate. There appear
to be two broad pathways to caspase ac-

Vol. 32, No. 3 (2002)
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tivation: signal transduction and mitochondrial release of cytochrome c,
though they are not mutually exclusive.

tochondrial membrane potential are
early apoptotic events detectable by the
techniques described below.

Signal Transduction

Mitochondrial Release of
Cytochrome C

Signal transduction involves receptors of the tumor necrosis factor (TNF)
family, which includes the C95/Fas and
TNFR1 receptors. Antibodies for the
detection of these receptors are available. At the Fas receptor, ligands cause
receptor clustering and the formation of
an intracellular complex with a protein
that includes a Fas-associated death domain (FADD). This domain is specialized to interact with and activate caspase 8. Domains on other proteins that
interact with caspases are collectively
known as caspase recruitment domains
(CARDs). Caspase 8 activates caspases
3, 6, and 7 and with them attacks cell
substrates, leading to the orderly
changes of programmed cell death.
Caspase 8 also cleaves the bcl-2 family
protein bid (see below), which is involved in the release of cytochrome c
from mitochondria.
The TNFR1 receptor is activated by
TNF produced mostly by immune cells
responding to infection. As with the
CD95 ligand, TNF binding produces
receptor clustering, and an adapter protein, TNFR associated death domain
(TRADD), is present. In contrast to
more direct CD95-associated activation
of a caspase, TRADD stimulates the
activation of nuclear transcription factors NFκ B and JNK, which is involved
with the synthesis of inhibitor of apoptosis proteins (IAPs). Here, apoptosis is
more likely when protein synthesis is
inhibited, and inhibition of NFκ B
makes programmed cell death more
likely (2). Caspase 8 appears to be involved in this receptor-mediated pathway. Figure 6 diagrams the major signaling pathways.

Cytochrome c is a heme-containing
component of the electron transport
chain in mitochondrial membranes. It is
released from mitochondria in some
forms of apoptosis, particularly those
dependent on the interaction of proand anti-apoptotic members of the bcl2
family. The mechanism of cytochrome
c release is unknown but probably involves interactions of pro-apoptotic
bcl-2 family proteins (see below) with
structures like the adenine nucleotide
transporter (ANT) and the voltage-dependent ion channel (VDAC) in the mitochondrial membrane (24). Release is
significant, for it allows activation of
caspase 9 with subsequent activity of
caspases 3, 6, and 7. Signal transduction through Fas or TNF receptors with
activation of caspase 8 also stimulates
cytochrome c release via the cleavage
products of bcl-2 family member bid.
Immunofluorescent microscopy can
detect released cytochrome c within
cells. ELISA and Western blot analysis
can quantitate cytochrome c released
into the media of cultured cells or isolated from homogenized cells.

656 BioTechniques

Recently, voltage sensitive dyes
have been used to study the mitochondrial membrane potential in whole cells
(4). The uptake of most mitochondrialselective dyes is dependent on the mitochondrial membrane potential. A
number of cell-membrane-permeable
mitochondrial-selective dyes are available (Molecular Probes, Eugene, OR,
USA). Some of these MitoTracker
probes such as MitoTracker Orange and
MitoTracker Red accumulate in active
mitochondria and withstand fixation.
These dyes are suitable for double-label studies with antibodies. The dualemission potential-sensitive probes
such as JC-1 and JC-9 are non-fixable
mitochondrion-selective probes useful
for the detection of the disruption of the
mitochondrial membrane. At low membrane potential, cells exposed to JC-1
fluoresce green, and at higher concentration (above 0.1 µM) they fluoresce
red. The ratio of red to green JC-1 fluorescence is dependent only on the
membrane potential and not other factors such as mitochondrial size, shape,
and density that may influence other
fluorescent signals. Thus, the dualemission dyes can be used to investigate the mitochondrial potentials in live
cells by ratiometric techniques (50).
Bcl-2 Gene Family: Pro- and AntiApoptotic

Probes for Mitochondria
The release of cytochrome c and
changes in the mitochondrial membrane potential are major markers of
apoptosis. There is much debate over
which of these events occur first or
whether they occur simultaneously.
Nevertheless, both the release of cytochrome c and the changes in the mi-

Mitochondrion-Selective Markers

Figure 3. DNA ladder in glioblastoma cells
treated with staurosporine. St denotes the migration distance and size (bp) of DNA standards.
(A) Control cells. (B) Internucleosomal DNA
ladder produced after staurosporine treatment.
(C) Glioblastoma treated with etoposide do not
show DNA fragmentation.

The bcl-2 gene family is important in
both preventing and permitting apoptosis and is intimately involved in cytochrome c release from mitochondria.
Overexpression of anti-apoptotic bcl-2
marker prevents apoptosis in the neurons of transgenic mice during experimental ischemia (40). Bcl-2 probably
has multiple sites of influence in preventing apoptosis. The balance between
pro- and anti-apoptotic bcl-2 family
members helps determine whether programmed cell death occurs. The story
becomes more complicated when different cell lines at different developmental stages with different death stimuli are considered. For example, there is
recent evidence that in developing neurons, neither bax nor caspase 3 is required for apoptosis (20). Bcl-2 family
proteins have been studied by immunoVol. 32, No. 3 (2002)
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chemical and standard protein quantification techniques. Transgenic mice
overexpressing bcl-2 family members
or lacking one or more bcl-2 family
genes have also been important in elucidating the signaling pathways.
Anti-apoptotic bcl-2 family members are associated with the outer mitochondrial membrane and are thought to
contribute to mitochondrial integrity by
affecting ATP trafficking, membrane
potential, and the channel or pore
through which cytochrome c is released
(42). In HeLa and cerebellar neurons
treated with staurosporine or serum deprivation, pro-apoptotic bid, translocated from cytosol to mitochondria, induced a conformational change in bax,
and allowed cytochrome c release into
the cytosol (17). Bax was associated
weakly with the outer mitochondrial
membrane before interacting with bid
but strongly associated after the interaction. Induced conformational change
may permit bax dimers to form and insert into the mitochondrial membrane.

Anti-apoptotic properties of bcl-2
and bcl-xl derive in part from interfering with the bid-bax interaction, though
they apparently bind to a different site
on bax than bid does. A transgenic
mouse study found that bax-deficient
sympathetic neurons were protected
from nerve growth factor (NGF)-induced apoptosis but showed significant
metabolic changes and atrophy (14).
An emerging view is that the BH3-only
members of the bcl-2 family connect
Fas-mediated and other death signals to
the mitochondria by altering the conformation of other mitochondrially associated bcl-2 family members such as
bad (17) and bak (65).
Proteolytic Effectors: Caspases
and Calpains
Effector proteases carry out the
death program by enzymatic actions on
substrates like PARP (decoupling DNA
damage from repair), lamins (changing
the structure of the nucleus), and the inhibitor of caspase-activated deoxynuclease (ICAD), resulting in DNA fragmentation. The first caspase was called
interleukin 1 β-converting enzyme
(ICE) since it activated IL-1b. By analogy with a protease active in nematode
apoptosis—ced 3 in Caenorhabditis elegans—the existence and pathways of

mammalian caspases began to be studied. One review of mammalian caspases (42) defines two phylogenetic
groups: those analogous to ced3, including caspases 3, 6, 7, 8, 9, and 10,
and those analogous to caspase 1, including caspases 4, 5, and 13. The ced3
group has proven roles in apoptosis.
The activation of caspase 9 by mitochondrial damage, release of cytochrome c, and interactions with Apaf1
was described above, along with receptor-mediated activation of caspases 8
and 10. In general, “upstream” caspases 8 and 9 activate the “downstream”
caspases 3, 6, and 7 with multiple targets throughout the cell. Caspase substrates are reviewed in Reference 9.
There are three main substrate target
groups: large aromatic group amino
acids, aliphatic or hydrophobic group
amino acids, and a large group targeting aspartate (42). Important nuclear
targets include ICAD and PARP, which
are cleaved by caspases 3 and 7. Caspase 6 cleaves lamins. The cleavage
products are readily recognized on immunoblots using enzyme-specific antibodies. Available kits measure caspase
activity in cell extracts (e.g., Promega
and Calbiochem-Novabiochem). Kits
are also available for studies of caspase
activation and subsequent downstream
events in whole cells using flow cytom-

Figure 4. DNA fragmentation enzyme immunoassay. The cell death ELISA is a spectrophotometric assay that allows the detection of internucleosomal degradation of genomic DNA that occurs during apoptosis. Cells treated with staurosporine show a significant increase in DNA fragmentation 5 h after treatment.
Vol. 32, No. 3 (2002)
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Table 2. Comparison of Commonly Used Methods in Studies of Apoptosis
Sensitivitya

Time Detectionb

Method of Detection

Bisbenzamide

++

Intermediate

Fluorescence microscope

Detection of chromatin condensation in viable
and non-viable cells (Hoechst 33342)

DNA Ladder

++

Intermediate

Gel electrophoresis

Detection of fragmentation of genomic DNA

Cell Death Detection
ELISA Plus

++

Intermediate

ELISA

Quantification of histone complexed DNA
fragments

PARP Cleavage

+++

Early

Western blots

Detection of the cleaved form of PARP, a
target for some caspases

TUNEL-TdT
Labeling

++

Intermediate

Fluorescent or light
microscopy, flow cytometry

Detection of dsDNA breaks, independent
of a template

In situ nick
translation using
Klenow fragments

+++

Intermediate

Fluorescent or light
microscopy

Detects one strand of dsDNA nicks.
Template dependent

Lamin B cleavage

++

Late

Western blots, light or
fluorescent microscopy

Degradation of Lamin B. breakdown of
nuclear envelope

Caspase Activity

+++

Very early

ELISA

In vitro detection and quantification of
caspase activity

Caspase Cleavage

+++

Early

Western blots,
immunocytochemistry

Detection of proteolytic cleavage products

Cytochrome c and
AIF release

+++

EarlyIntermediate

Western blots

Detection of disruption of mitochondrial
permeability. Cytochrome c release
promotes caspase activation

Annexin V

++

EarlyIntermediate

Flow cytometry,
fluorescent microscopy

Detection of apoptotic cells with cytoplasmic
membrane alterations (phosphatidylserine
translocation)
Differentiation of apoptotic from necrotic cells
by simultaneous staining with propidium
iodide

Apoptosis-related
++
proteins:
(a) FAS (CD95/Apo-1)

Intermediate

Immunocytochemistry,
flow cytometry or
Western blots

Detection of cell surface receptor genes
that could mediate apoptotis cell death

Assays

Useful for

(b) Bel-2
protooncogene

++

Early

Immunocytochemistry
or Western blots

Detection of the apoptosis suppressing
Bcl-2 protein

(c) P53 tumor
suppressor

++

Intermediate

Immunocytochemistry

Detection of p53 protein. Induces apoptosis
in potentially malignant cells

aThe

sensitivity of a technique is arbitrarily divided into three categories: +++, very sensitive; ++, moderately sensitive; and +, low sensitivity.
of detection is divided into three categories and is based on the initial time when apoptosis was induced.

bTime

etry or fluorescent microscopy. Targets
and relative specificity of the caspases
are still being worked out. Caspases
can also be activated by a killer T-cell
serine protease, granzyme B (47).
Caspase Inhibitors
TNF receptor activation can result in
apoptosis, yet also involves the synthesis
of IAPs via transcription factor activity.
These proteins likely work in part by inhibiting caspases (60). Inhibitors of the
IAPs themselves such as Grim and
660 BioTechniques

Reaper have been described in Drosophila, and a recent report (62) indicates
that the vertebrate protein diablo/smac
can remove IAP inhibition and make
transfected human cells sensitive to UV.
Other anti-apoptotic proteins are
produced by viruses and include the
false-substrate baculovirus protein p35.
This protein has been shown to specifically inhibit caspases 3, 6, 7, 8, and 10
(73) and to inhibit apoptosis in transgenic mice expressing the protein (63).
A cell-permeable false-substrate caspase inhibitor, benzyloxycarbonyl V-A-

D(OMe)-fluoromethylketone (zVADfmk), also has broad caspase-inhibiting
properties and has been shown to ameliorate ischemic injury in brain tissue
(12). Other inhibitors targeted to specific caspases before their activation
may prove useful in delaying or preventing cell death.
In addition to the caspase family of
apoptotic proteases, the protease calpain
has also been implicated in apoptosis
(57). Drug-induced apoptosis via caspase 9 implicates calpain in the cleavage
of bax (67). In rat spinal cord injury, proVol. 32, No. 3 (2002)
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tection was afforded from apoptotic cell
death by calpain inhibition (51). Calpain
may be activated before caspases in
apoptosis induced by radiation (64). In a
mutant mouse model, calpain protein
was increased in brain and spinal cord in
the setting of apoptotic cell death, as
measured by in situ hybridization and
Western blot methods (36).
The transcription-regulating p53
gene product is up-regulated from negligible baseline nuclear amounts in the
face of DNA damage. DNA damage can
be readily detected with the techniques
described above. The accumulation of
wild-type p53 following DNA damage
leads to either DNA repair following
cell cycle arrest or apoptosis. When
DNA damage includes a mutation in the
p53 gene itself, DNA repair and apoptotic responses are defective, and cancer
may result. p53 mutations are present in
40%–45% of human cancers (56).
The apoptotic function may result
from p53-mediated up-regulation of
bax and down-regulation of bcl-2 (45);
a p53-negative response element has
been identified in the bcl-2 gene (44).
Colorectal cells lacking functional p53
undergo apoptosis after wild-type p53
is added with a viral vector (48), and a
similar gene transfer resulted in apoptosis in post-mitotic neurons (54).

sis and the in situ nick translation (ISNT)
and TUNEL. TUNEL labels blunt ends
of dsDNA breaks independent of a template. On the other hand, ISNT, which
uses Klenow (DNA polymerase I), catalyzes the template-dependent addition
of nucleotides when one stand of a dsDNA molecule is nicked. This technique
detects DNA damage earlier than
TUNEL (19) and is useful in detecting
not only apoptosis but also the random
fragmentation of DNA by multiple endonucleases. TUNEL and ISNT are both
based on DNA strand breaks and label
both apoptotic and necrotic cells.
DNA dyes such as propidium iodide
(non-intercalating) and Hoescht 33342
(intercalating) reveal apoptotic nuclear
morphology and can be visualized directly under light, fluorescent, or confocal laser microscopy. These can be
combined with annexin V techniques
(see below) to distinguish necrotic from
apoptotic cells. Alternatively, DNA ladders indicate that nucleosomal cleavage
has taken place but do not show what
proportion of cells in the sample exhibits this pattern. Furthermore, not all
cells undergoing apoptosis show a
DNA ladder. Thus, the importance of
using more then one independent assay

cannot be overemphasized.
Membrane changes in both the whole
cell and mitochondrial membranes occur during apoptosis. Phosphatidylserine
relocates from the inside to the outside
of the cell membrane early in the process. Annexin V, a calcium-dependent
binding protein specific for phosphatidylserine, binds to the surface of the
apoptotic cells. This labeling is detected
with flow cytometry or fluorescent microscopy. Double labeling of cells with
annexin V and propidium iodide can
readily distinguish apopototic from nectrotic cells. In the mitochondria, the
change in the membrane potentials associated with the release of cytochrome c
serves as an important marker of apoptosis. This change in potential can be assessed with voltage-sensitive dyes. The
release of cytochrome c can be assessed
with Western blots.
Enzymes, particularly the caspases,
affect the apoptotic program as outlined
above. Detection of the enzymes themselves, as a form of protein, or the results
of their activity on substrates forms a
third category of apoptosis detection.
The products of PARP (early) and lamin
B (late) cleavage can be assessed with
Western blots or immunocytochemical

OVERVIEW OF COMMONLY
USED TECHNIQUES IN STUDIES
OF APOPTOSIS
Numerous methods have been utilized to detect apoptosis. Some of these
techniques are summarized in Table 2.
This list is by no means inclusive but
gives an overview of common methods
used to study apoptosis based on the desired experimental endpoint. It is important to emphasize the need for concordant (positive) results from several
techniques before asserting the presence
of apoptosis in a given system. A useful
framework for organizing these methods
comprises four categories: DNA
changes, membrane changes, enzyme
activity, and apoptosis-regulating genes.
Within each category, there may be multiple assays and detection methods.
Methods based on the characteristic
DNA changes of apoptosis include DNA
dyes, DNA ladders on gel electrophore662 BioTechniques

Figure 5. Western blots showing cleavage of PARP and lamin B after exposure of neuroblastoma
cells to staurosporine. (A) Cleavage of PARP into an 85-kDA product is seen 1 h after treatment. (B)
Cleavage of lamin into a 43-kDA band is noticeable 8 h after treatment and is most pronounced 12 h after
exposure to staurosporine. This suggests that the dissolution of the nuclear membrane occurs after PARP
becomes inactive.
Vol. 32, No. 3 (2002)

Figure 6. A signal that activates the TNF, Fas receptor, or the withdrawal of growth factors initiates
the apoptotic cascade. Both of these events activate caspases. The receptor-mediated pathway activates
caspase 8, followed by downstream caspases. This results in the cleavage of many substrates or the activation of transcription factors such as NFκ B and the release of pro-apoptotic factors such as apoptosisinducing factor, cytochrome c, and apoptosis protease activating factor (Apaf-1) into the cytosol. There is
also the IAP family of proteins that prevent cell death by binding to and inhibiting active caspases. Caspases can also be activated via the mitochondrial pathway. Here the Bcl-2 family associates with the mitochondria and releases cytochrome c and other proteins that activate caspase 9, followed by the downstream caspases. Both pathways lead to the activation of caspase 3, which is considered the “central
executioner of apoptosis”.

methods. Quantitative, in vitro caspase
activity can also be assessed as a very
early marker of apoptosis using ELISA.
The fourth category of apoptosis detection focuses on signaling proteins
such as FAS/CD95, the bcl2 protooncogene, and the p53 tumor suppressor
gene product. These can be detected using immunocytochemistry, Western
blotting, or flow cytometry.
Thus, there are many methods for
studying apoptosis at different stages in
the process by visualizing or detecting
the signals that initiate and regulate it,
the enzymes that carry the program out,
and the resulting products. Appropriately chosen methods should allow sound
conclusions to be drawn regarding the
presence of apoptosis in a given system.
CONCLUSION
Apoptosis is a highly conserved biological program that has attracted pheVol. 32, No. 3 (2002)

nomenal research interest since the
mid-1980s. Its appeal rests on intrinsic
interest and the dual potential for uniting theories of pathology and inspiring
new therapies in virtually every organ
system. First described using the electron microscopic techniques of the
1970s, morphologic criteria are still important for asserting apoptotic cell
death. These and newer methodologies
are of crucial importance in enhancing
our understanding of apoptotic pathways. Emerging details about these
pathways have deepened and extended
our appreciation for the role of apoptosis in normal development, including
massive CNS neuronal pruning in early
life, homeostatic functions such as tumor surveillance, neurodegenerative
diseases, and brain injury.
Recent research has revealed much
about the mechanisms of apoptotic
death and how it occurs. An overview
is shown in Figure 6. Stimuli arising in
the nucleus (DNA damage and p53 in-
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duction), the mitochondria (with release of cytochrome c and activation of
caspase 9 through the apoptosome), or
the cell surface (via members of the
TNF receptor family, including Fas and
TNFR1) can ultimately activate caspases and give rise to apoptotic cell death.
Much remains unknown about the
mechanisms of apoptosis within cells
and the relationship between death
pathways that overlap. Moreover, signals and effectors of cell death pathways may have multiple roles with intriguing connections to other cell
functions such as cellular plasticity.
There are also important questions
about the benefits of modifying apoptotic programs in clinical situations.
The functionality of cells rescued from
apoptosis initiated by physiologic stimulus is a fundamental question. Effective delivery of apoptosis-inhibiting or
promoting agents (e.g., through viral
vectors or targeted parenteral infusion)
will also be challenging, particularly in
the blood-brain-barrier-protected CNS.
Given the existence and importance
of apoptosis, one of the most fundamental questions for those researching its
mechanisms is, “is it present?” From
there, one asks whether it is primary or
secondary to a separate underlying
pathology and whether or not modifying
apoptotic programs will be demonstrably beneficial. The common methods
reviewed above for detecting apoptosis
address the first question. The methods
for inducing apoptosis can help to unravel the other questions. As more is
learned, new techniques with increasing
specificity can be anticipated.
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